Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic heart failure

Heart Failure Society of America (HFSA) practice guidelines, 1999, HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches, J Card Fail, 5, 357, 10.1016/S1071-9164(99)91340-4 Jessup, 2003, Heart failure, N Engl J Med, 348, 2007, 10.1056/NEJMra021498 National Heart, Lung, and Blood Institute Gomberg-Maitland, 2001, Treatment of congestive heart failure: Guidelines for the primary care physician and heart failure specialist, Arch Intern Med, 161, 342, 10.1001/archinte.161.3.342 1991, Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators, N Engl J Med, 325, 293, 10.1056/NEJM199108013250501 1999, The Cardiac Insufficiency Bisoprolol Study II (CIBISII): A randomised trial, Lancet, 353, 9, 10.1016/S0140-6736(98)11181-9 1999, Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF), Lancet, 353, 2001, 10.1016/S0140-6736(99)04440-2 Packer, 1996, The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group, N Engl J Med, 334, 1349, 10.1056/NEJM199605233342101 1997, The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group, N Engl J Med, 336, 525, 10.1056/NEJM199702203360801 Pitt, 1999, The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators, N Engl J Med, 341, 709, 10.1056/NEJM199909023411001 Murray, 2001, Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure, Am J Med, 111, 513, 10.1016/S0002-9343(01)00903-2 O'Connor, 1999, Current and novel pharmacologic approaches in advanced heart failure, Heart Lung, 28, 227, 10.1016/S0147-9563(99)70069-5 Murray, 1986, Factors contributing to medication noncompliance in elderly public housing tenants, Drug Intell Clin Pharm, 20, 146, 10.1177/106002808602000210 Hussey, 1991, Overcoming the clinical barriers of low literacy and medication noncompliance among the elderly, J Gerontol Nursing, 17, 27, 10.3928/0098-9134-19910301-12 Murray, 1999, Work patterns of ambulatory care pharmacists with access to electronic guideline-based treatment suggestions, Am J Health Syst Pharm, 56, 225, 10.1093/ajhp/56.3.225 McDonald, 1999, The Regenstrief Medical Record System: A quarter century experience, Int J Med Inform, 54, 225, 10.1016/S1386-5056(99)00009-X Murray, 2003, Structure, functions, and activities of a research support informatics section, J Am Med Inform Assoc, 10, 389, 10.1197/jamia.M1252 Weinberger, 2001, Pharmaceutical care program for patients with reactive airways disease, Am J Health Syst Pharm, 58, 791, 10.1093/ajhp/58.9.791 Lorig, 1996 Morrow, 1997, Improving consultations between healthcare professionals and older clients: Implications for pharmacists, Int J Aging Hum Dev, 44, 47, 10.2190/GQX9-F4UJ-5RQ2-N1YD Morrow, 1991, Elders' schema for taking medication: Implications for instruction design, J Gerontol, 48, P378, 10.1093/geronj/46.6.P378 Morrow, 1988, Adherence and medication instructions. Review and recommendations, J Am Geriatr Soc, 36, 1147, 10.1111/j.1532-5415.1988.tb04405.x Murray, 1998, Determining the effectiveness of torasemide and furosemide in heart failure. Design of a randomised comparison using the Regenstrief Medical Record System, Clin Drug Invest, 16, 45, 10.2165/00044011-199816010-00006 Morrow DG, Weiner M, Deer M, et al. Patient-centered instructions for medications prescribed for the treatment of heart failure. Am J Geriatr Pharmacother. In press. Lorig, 1999, Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: A randomized trial, Med Care, 37, 5, 10.1097/00005650-199901000-00003 Gattis, 1999, Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: Results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study, Arch Intern Med, 159, 1939, 10.1001/archinte.159.16.1939 Park, 1997, Medication adherence and aging, 257 Murray, 1990, Adverse effects of nonsteroidal anti-inflammatory drugs on renal function, Ann Intern Med, 112, 559, 10.7326/0003-4819-112-8-559 Murray, 1997, The effect of nonsteroidal antiinflammatory drugs on electrolyte homeostasis and blood pressure in young and el derly persons with and without renal insufficiency, Am J Med Sci, 314, 80, 10.1097/00000441-199708000-00009 Morrow, 1995, List formats improve medication instructions for older adults, Educ Gerontol, 21, 151, 10.1080/0360127950210204 Morrow, 1996, Medication instruction design: Younger and older adult schemas for taking medication, Hum Factors, 38, 556, 10.1518/001872096778827305 Flesch-Kincaid Morrow, 1999, Designing medication instructions for older adults, 249 Kline, 1997, Sensory and perceptual functioning: Basic research and human factors implications, 27 Gattis, 1998, Is optimal angiotensin-converting enzyme inhibitor dosing neglected in elderly patients with heart failure?, Am Heart J, 136, 43, 10.1016/S0002-8703(98)70180-2 Avorn, 1983, Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based “detailing”, N Engl J Med, 308, 1457, 10.1056/NEJM198306163082406 1996 New York Heart Association, 1964 Green, 2000, Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: A new health status measure for heart failure, J Am Coll Cardiol, 35, 1245, 10.1016/S0735-1097(00)00531-3 Guyatt, 1989, Development and testing of a new measure of health status for clinical trials in heart failure, J Gen Intern Med, 4, 101, 10.1007/BF02602348 1996, General health status and quality of life, 380 Miller, 1997, The multilevel compliance challenge: Recommendations for a call to action. A statement for healthcare professionals, Circulation, 95, 1085, 10.1161/01.CIR.95.4.1085 Roter, 1998, Effectiveness of interventions to improve patient compliance: A meta-analysis, Med Care, 36, 1138, 10.1097/00005650-199808000-00004 Haynes, 2000, Interventions for helping patients to follow prescriptions for medications, Cochrane Database Syst Rev, CD000011 1999 2000